1-3 of 3
Paul Lloyd-Evans
Close
Sort by
Journal Articles

Autologous Stem Cell Transplantation in AL-Amyloidosis Following Yttrium-90 Labelled Anti-CD66 Monoclonal Antibody As Sole Conditioning Is Associated with Low Toxicity and Demonstrable Disease Responses

Kim H. Orchard, Jon Langford, Paul Lloyd-Evans, Denise Phillips, Matthew Guy, Sofia Michopoulou, Gemma Lewis, Julian Williams, Clint Zvavamwe, Claire Hutchison, Jane Nunnick, Amanda Blackwell, Pei-San Chan, Caspar Wickham, Ann-Marie Quigley, Mark Cook, Graham Jackson, Philip N Hawkins, Ashutosh D. Wechalekar
Journal: Blood
Blood (2021) 138 (Supplement 1): 3819.
https://doi.org/10.1182/blood-2021-146300
Published: 2021
Journal Articles

Recombinant HPA-1a antibody therapy for treatment of fetomaternal alloimmune thrombocytopenia: proof of principle in human volunteers

Cedric Ghevaert, Nina Herbert, Louise Hawkins, Nicola Grehan, Philip Cookson, Steve F. Garner, Abigail Crisp-Hihn, Paul Lloyd-Evans, Amanda Evans, Kottekkattu Balan, Willem H. Ouwehand, Kathryn L. Armour, Mike R. Clark, Lorna M. Williamson
Journal: Blood
Blood (2013) 122 (3): 313–320.
https://doi.org/10.1182/blood-2013-02-481887
Published: 2013
Includes: Supplemental data
Journal Articles

Intravascular survival of red cells coated with a mutated human anti-D antibody engineered to lack destructive activity

Clinical Trials & Observations
Kathryn L. Armour, David R. Parry-Jones, Nigel Beharry, James R. Ballinger, Rosey Mushens, R. Keith Williams, Cynthia Beatty, Simon Stanworth, Paul Lloyd-Evans, Marion Scott, Michael R. Clark, A. Michael Peters, Lorna M. Williamson
Journal: Blood
Blood (2006) 107 (7): 2619–2626.
https://doi.org/10.1182/blood-2005-03-0989
Published: 2006